NFE2L2 and cardiovascular disorder: In this regard, nuclear factor-erythroid factor 2-related factor 2 (Nrf2), which has been historically considered as a master transcription factor of antioxidant defense, has evolved as an attracting therapeutic target for cardiovascular disease (Li et al., 2009a; Chen and Maltagliati, 2018; Ge et al., 2019).